BioCryst Pharmaceuticals Inc

BO1.DU·Dusseldorf
Compare
6.84−0.02 (−0.29%)today
As of Oct 23, 9:30 AM CEST · May be delayed up to 15 min · EUR

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close6.86
Open6.84
Day range6.846.84
52-week range5.209.89
Off day high0.00%
Off 52-week high−30.85%
Volume0.00
Avg. volume (3M)0.00
Market cap—
EPS (TTM)—
Forward P/E—
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)—
Shares outstanding—
Short interest—
Earnings dateNov 4, 2026
Analyst target—
Profit margin—

Against its peers

Compare in full ›
BO1.DU BIIB BIOCON.NS BIVI BMRN CBIO
Market cap — 37.51B 530.63B 11.11M 10.96B 488.11M
P/E (TTM) — 45.1 95.9 — 153.1 —
Forward P/E — 15.4 29.6 -2.2 8.8 -5.0
Price/book — 2.0 1.5 0.9 1.7 2.8
Dividend yield — — 0.15% — — —
1-year change +11.69% +69.14% −8.83% −32.28% +3.81% +2.74%
Today −0.29% +5.34% −1.93% +1.59% +2.57% −0.23%

The closest companies by business. Prices may be delayed up to 15 min.

Latest news

All BO1.DU news ›

From articles in the 4Search news index.

In the news

2mentions in 30 days
2with it in the headline
Positivesentiment

Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 2 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Search index. Terms of use.